Combination Drug Therapy for COPD Exacerbation and Mortality

Research summary

Gerard J. Criner, MD, Director/Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses a recent clinical trial with combination drug therapies in COPD exacerbation and mortality.

References and Resources
Calverley P, Anderson J, Celli B, et al. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. NEJM. Feb 2007; Vol 356:775-789.
Click Here to view abstract.

Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet
American Lung Association
Click Here to view fact sheet.

Environmental Hazards & Health Effects – Chronic Obstructive Pulmonary Disease (COPD)
CDC
Click Here to view information.

The Critical Care Channel

Combination Drug Therapy for COPD Exacerbation and Mortality

Research summary

More in Critical Care

ECMO Transfusion Support

Anesthesiology

What Effects Might the Pandemic Have On HCP Rates of Suicide, PTSD, and Medical Burnout?

COVID-19

Occupational Therapy Provides Support and Continuity for ICU Patients During the COVID-19 Pandemic

COVID-19

Would Your Patients Wear a Laboratory on Their Wrists?

Cardiology